Cochlear backs Epiminder capital raising
Medical device innovator Epiminder has raised $18 million in bridging funding to support the development of its lead product Minder, which aims to revolutionise the lives of millions of people suffering from epilepsy and seizures. The raising was supported by existing shareholders Cochlear, the Bionics Institute, the University of Melbourne, Seer Medical and private investors.…
Details